Retevmo 80 mg

Retevmo 80 mg capsules contain selpercatinib, a medication used to treat certain types of cancer. This oral medication is designed to target specific genetic mutations. Learn more about selpercatinib and its uses.

Retevmo 80 mg capsules are primarily used in the treatment of advanced cancers that harbor specific genetic alterations. Selpercatinib is often prescribed for patients with non-small cell lung cancer, thyroid cancer, and other solid tumors that exhibit RET gene fusions or mutations. This medication works by targeting the RET protein, which can help slow the growth and spread of cancer cells. Patients should consult their healthcare provider to determine if selpercatinib is suitable for their condition.

Common effects of Retevmo 80 mg capsules may include fatigue, diarrhea, and nausea. Some patients may also experience changes in taste, dry mouth, or constipation. These effects can vary in severity and duration. It is important to discuss any persistent or bothersome symptoms with a healthcare professional.

Retevmo 80 mg capsules should be handled with care and stored as directed. Patients should avoid breaking or crushing the capsules unless instructed to do so by a healthcare provider. It is important to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects. Pregnant women or those planning to become pregnant should consult their healthcare provider before starting selpercatinib.

Selpercatinib may interact with certain medications, including those that are metabolized by the liver's CYP3A enzyme system. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of selpercatinib.